Position in BLLN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$32,090,057
+$16,555,271 QoQ
Shares Held
406,512
+114.2% QoQ
Ownership
0.884%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,089,419,006 across 33 Diagnostics & Research names. BLLN ranks #21 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,235,720 | $1,098,923,441 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,671,121 | $938,986,178 | |
| 3 | DHR |
Danaher Corp /De/
|
4,021,153 | $762,410,603 | |
| 4 | WAT |
Waters Corp /De/
|
2,168,285 | $645,715,268 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
3,261,778 | $556,263,609 | |
| 6 | GH |
Guardant Health, Inc.
|
4,946,469 | $456,905,334 | |
| 7 | ICLR |
Icon PLC
|
3,878,869 | $429,235,636 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
2,397,252 | $413,525,968 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,090,057 | 406,512 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $15,534,786 | 189,819 | Shares | Defined | 2026-02-19 | |
| No filing history on record for this holder in this stock. | ||||||